211 related articles for article (PubMed ID: 23661140)
1. Vascular access versus the effect of statins on inflammation and fibrinolysis in renal dialysis patients.
do Sameiro Faria M; Ribeiro S; Rocha-Pereira P; Miranda V; Quintanilha A; Reis F; Costa E; Belo L; Santos-Silva A
J Vasc Access; 2013; 14(4):335-41. PubMed ID: 23661140
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between inflammation,coagulation/fibrinolysis and vascular access in hemodialysis patients.
Costa E; Rocha S; Rocha-Pereira P; Castro E; Reis F; Teixeira F; Miranda V; Do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
J Vasc Access; 2008; 9(4):248-53. PubMed ID: 19085894
[TBL] [Abstract][Full Text] [Related]
3. Changes in inflammatory markers during a hemodialysis session and their relation to vascular access type.
Rozen-Zvi B; Erman A; Korzets A; Levy-Drummer RS; Chagnac A; Khaskiya M; Zingerman B; Ori Y
J Vasc Access; 2012; 13(4):446-51. PubMed ID: 22729528
[TBL] [Abstract][Full Text] [Related]
4. Association of vascular access type with inflammatory marker levels in maintenance hemodialysis patients.
Dukkipati R; Molnar MZ; Park J; Jing J; Kovesdy CP; Kajani R; Kalantar-Zadeh K
Semin Dial; 2014; 27(4):415-23. PubMed ID: 24118625
[TBL] [Abstract][Full Text] [Related]
5. Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.
Banerjee T; Kim SJ; Astor B; Shafi T; Coresh J; Powe NR
Am J Kidney Dis; 2014 Dec; 64(6):954-61. PubMed ID: 25266479
[TBL] [Abstract][Full Text] [Related]
6. Type of vascular access and location in online hemodiafiltration and its association with patient's perception of health-related quality of life.
Moura A; Madureira J; Alija P; Fernandes JC; Oliveira JG; Lopez M; Filgueiras M; Amado L; Sameiro-Faria M; Miranda V; Vieira M; Santos-Silva A; Costa E
J Vasc Access; 2014; 15(3):175-82. PubMed ID: 24170586
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin is an independent predictor of tissue plasminogen activator levels in patients under haemodialysis.
do Sameiro Faria M; Ribeiro S; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Costa E; Belo L; Santos-Silva A
Scand J Urol Nephrol; 2012 Dec; 46(6):461-5. PubMed ID: 22852746
[TBL] [Abstract][Full Text] [Related]
8. Tongqiaohuoxue decoction ameliorates obesity-induced inflammation and the prothrombotic state by regulating adiponectin and plasminogen activator inhibitor-1.
Kim SH; Park HS; Hong MJ; Yoo JY; Lee H; Lee JA; Hur J; Kwon DY; Kim MS
J Ethnopharmacol; 2016 Nov; 192():201-209. PubMed ID: 27404230
[TBL] [Abstract][Full Text] [Related]
9. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
[TBL] [Abstract][Full Text] [Related]
10. Hemodialysis vascular access in children and adolescents: a ten-year retrospective cohort study.
Souza RA; Oliveira EA; Silva JM; Lima EM
J Bras Nefrol; 2011 Dec; 33(4):422-30. PubMed ID: 22189805
[TBL] [Abstract][Full Text] [Related]
11. Vascular access for hemodialysis: the impact on morbidity and mortality.
Di Iorio BR; Bellizzi V; Cillo N; Cirillo M; Avella F; Andreucci VE; De Santo NG
J Nephrol; 2004; 17(1):19-25. PubMed ID: 15151255
[TBL] [Abstract][Full Text] [Related]
12. Effect of statins on chronic inflammation and nutrition status in renal dialysis patients: a systematic review and meta-analysis.
Deng J; Wu Q; Liao Y; Huo D; Yang Z
Nephrology (Carlton); 2012 Aug; 17(6):545-51. PubMed ID: 22429568
[TBL] [Abstract][Full Text] [Related]
13. Predialysis nephrology care amongst Palestinian hemodialysis patients and its impact on initial vascular access type.
Atieh AS; Shamasneh AO; Hamadah A; Gharaibeh KA
Ren Fail; 2020 Nov; 42(1):200-206. PubMed ID: 32506996
[TBL] [Abstract][Full Text] [Related]
14. Determinants of venous catheter hemodialysis onset and subsequent switch to arteriovenous fistula: An epidemiological study in Lazio region.
Tazza L; Angelici L; Marino C; Di Napoli A; Bossola M; De Cicco C; Davoli M; Agabiti N
J Vasc Access; 2021 Sep; 22(5):749-758. PubMed ID: 32993439
[TBL] [Abstract][Full Text] [Related]
15. Predialysis nephrology care and its impact on initial vascular access type in hemodialysis patients in Jordan.
Hamadah AM; Gharaibeh K
Saudi J Kidney Dis Transpl; 2019; 30(5):1103-1110. PubMed ID: 31696849
[TBL] [Abstract][Full Text] [Related]
16. Influence of vascular access type on outcome measures in patients on maintenance hemodialysis.
Chand DH; Teo BW; Fatica RA; Brier M;
Nephron Clin Pract; 2008; 108(2):c91-8. PubMed ID: 18212514
[TBL] [Abstract][Full Text] [Related]
17. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
[TBL] [Abstract][Full Text] [Related]
18. Vascular access type and changes in inflammatory markers in incident dialysis patients: a pilot study.
Sachdeva M; Kovalchuk O; Bitzer M; Mokrzycki MH
J Vasc Access; 2009; 10(3):174-9. PubMed ID: 19670170
[TBL] [Abstract][Full Text] [Related]
19. Role of the hemodialysis vascular access type in inflammation status and monocyte activation.
Colì L; Donati G; Cappuccilli ML; Cianciolo G; Comai G; Cuna V; Carretta E; La Manna G; Stefoni S
Int J Artif Organs; 2011 Jun; 34(6):481-8. PubMed ID: 21725929
[TBL] [Abstract][Full Text] [Related]
20. Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.
Erdem Y; Haznedaroglu IC; Celik I; Yalcin AU; Yasavul U; Turgan C; Caglar S
Nephrol Dial Transplant; 1996 Jul; 11(7):1299-305. PubMed ID: 8672026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
